These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 19390931)
1. Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival. Ohtani S; Terashima M; Satoh J; Soeta N; Saze Z; Kashimura S; Ohsuka F; Hoshino Y; Kogure M; Gotoh M Gastric Cancer; 2009; 12(1):43-51. PubMed ID: 19390931 [TBL] [Abstract][Full Text] [Related]
2. Beclin 1 expression is an independent prognostic factor for gastric carcinomas. Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926 [TBL] [Abstract][Full Text] [Related]
3. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645 [TBL] [Abstract][Full Text] [Related]
4. TPX2 expression is associated with poor survival in gastric cancer. Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036 [TBL] [Abstract][Full Text] [Related]
5. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related]
6. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of claudin-4 in gastric carcinoma. Zhu JL; Gao P; Wang ZN; Song YX; Li AL; Xu YY; Wang MX; Xu HM World J Surg Oncol; 2013 Jul; 11():150. PubMed ID: 23822740 [TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival. Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561 [TBL] [Abstract][Full Text] [Related]
9. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma. Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498 [TBL] [Abstract][Full Text] [Related]
10. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma. Shi R; Wang L; Wang T; Xu J; Wang F; Xu M Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954 [TBL] [Abstract][Full Text] [Related]
11. The expression patterns of tight junction protein claudin-1, -3, and -4 in human gastric neoplasms and adjacent non-neoplastic tissues. Wang H; Yang X Int J Clin Exp Pathol; 2015; 8(1):881-7. PubMed ID: 25755790 [TBL] [Abstract][Full Text] [Related]
12. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma. Nagatsuma AK; Aizawa M; Kuwata T; Doi T; Ohtsu A; Fujii H; Ochiai A Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858 [TBL] [Abstract][Full Text] [Related]
13. Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Paschoud S; Bongiovanni M; Pache JC; Citi S Mod Pathol; 2007 Sep; 20(9):947-54. PubMed ID: 17585317 [TBL] [Abstract][Full Text] [Related]
14. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Resnick MB; Konkin T; Routhier J; Sabo E; Pricolo VE Mod Pathol; 2005 Apr; 18(4):511-8. PubMed ID: 15475928 [TBL] [Abstract][Full Text] [Related]
15. Tight junction protein claudin 4 in gastric carcinoma and its relation to lymphangiogenic activity. Shareef MM; Radi DM; Eid AM Arab J Gastroenterol; 2015; 16(3-4):105-12. PubMed ID: 26526513 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Aung PP; Mitani Y; Sanada Y; Nakayama H; Matsusaki K; Yasui W Virchows Arch; 2006 Apr; 448(4):428-34. PubMed ID: 16328347 [TBL] [Abstract][Full Text] [Related]
17. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005 [TBL] [Abstract][Full Text] [Related]
18. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients. Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987 [TBL] [Abstract][Full Text] [Related]
19. Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer. Kwon CH; Park HJ; Lee JR; Kim HK; Jeon TY; Jo HJ; Kim DH; Kim GH; Park DY Br J Cancer; 2014 Nov; 111(10):1993-2002. PubMed ID: 25211665 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]